Transforming the €40+ billion chronic wound care market

Active healing and real-time monitoring for all wounds

A bioelectronic dressing that accelerates wound healing and produces actionable healing data, moving care from passive management to active repair

See electric healing in action

Watch the video

At Bioelectrix, we believe the future of wound care is electric.

Our patented wound dressing delivers gentle direct current to reactivate stalled healing.

In this video we show how wounded cells react to stimulation with our technology. Resulting in 3x faster closure of a wound in healthy and diabetic human skin cells. 

The problem

Chronic wounds are a persistent global healthcare challenge, costing tens of billions annually and disproportionately affecting patients with diabetes

0 M+

people worldwide suffer from chronic wounds

“Chronic wounds are overlooked in the health care system. Old age, obesity and diabetes are making this worse.”

> 0 %

mortality in 5 years for Diabetic Foot Ulcers

“Once a wound has become chronic, time starts ticking for patients unless they can be cured…”

0 B€+

spent per year on chronic wounds

“We need better, cost-effective treatments for these wounds that can actively stimulate the healing process

Electric fields guide cells to close a wound, but this process fails in hard-to-heal wounds.

The Solution

From passive wound care to active healing. A new class of bioelectronic wound therapy

Bioelectrix is building a new class of wound care solution combining active bioelectric healing stimulation with real-time monitoring, designed to accelerate healing and create measurable outcomes for clinicians and payers alike.

Active healing at biological level

Restores natural electric fields guiding skin repair

Designed to accelerate closure in hard-to-heal wounds

Built for real world healthcare systems

Designed to reduced treatment duration and care costs

Fits existing wound care workflows and reimbursement logic

A scalable bioelectronic platform

Initial focus on diabetic foot ulcers

Expandable to other chronic and acute wounds

WHY NOW?

For decades, the biology of electric wound healing has been understood, but only now have materials, clinical need, and healthcare economics aligned to make active bioelectronic wound care viable

Materials and bioelectronics have reached clinical maturity

Only recently have metal free conductive materials and fabrication methods enabled safe, stable direct current stimulation on human tissue, overcoming the electrochemical limitations that blocked earlier approaches.

Chronic wounds have become a systemic healthcare crisis

Ageing populations and rising diabetes prevalence are driving an unprecedented increase in chronic wounds, creating urgency for solutions that actively accelerate healing rather than passively manage symptoms.

Healthcare systems are ready for outcome driven therapies

Payers and providers are increasingly prioritizing treatments that shorten care pathways, reduce complications, and enable outpatient management, creating a clear entry point for active, cost-effective wound therapies.

Bioelectrix sits at the intersection of these shifts, translating decades of bioelectric science into a clinically and commercially viable therapy.

Latest news

shaping the future of healing